|
|
||||||||
Clinical Chemistry, Vol 41, 147-152, Copyright © 1995 by American Association for Clinical Chemistry
PS Roheim and BF Asztalos
Louisiana State University Medical Center, Department of Physiology, New Orleans 70112-2822.
Correlation between coronary heart disease and lipoprotein size and composition is well documented. Within the low-density lipoprotein (LDL) family the small LDL particles are associated with increased risk of coronary heart disease. These particles also have increased apolipoprotein (apo) B content. The appearance of these small LDL particles is the manifestation of complex alteration of plasma lipoprotein metabolism. The LDL size is influenced by genetic, endocrine, and environmental factors. Within the high-density lipoprotein (HDL) family the decrease of larger HDL2 particles is associated with coronary heart disease. HDLs can also be separated according to their apoprotein composition into particles containing lipoprotein (Lp)A-I only and particles containing LpA-I and LpA-II. Most studies have shown that the concentration of LpA-I-only particles decreases in coronary heart disease. HDLs are remodeled in the circulation and this remodeling continues in vitro after the blood is taken. Therefore adequate preservation of blood samples is necessary.
The following articles in journals at HighWire Press have cited this article:
![]() |
G. L. Vega and G. Schonfeld In Memoriam: Paul S. Roheim (1925-2008) J. Lipid Res., March 1, 2009; 50(3): 361 - 363. [Full Text] [PDF] |
||||
![]() |
I. J. Kullo and C. M. Ballantyne Conditional Risk Factors for Atherosclerosis Mayo Clin. Proc., February 1, 2005; 80(2): 219 - 230. [Abstract] [PDF] |
||||
![]() |
D. L. Rainwater, P. H. Moore Jr., and I. O. Gamboa Improved method for making nondenaturing composite gradient gels for the electrophoretic separation of lipoproteins J. Lipid Res., April 1, 2004; 45(4): 773 - 775. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Bureau, F. Laporte, M. Favier, H. Faure, M. Fields, A. E. Favier, and A.-M. Roussel No Antioxidant Effect of Combined HRT on LDL Oxidizability and Oxidative Stress Biomarkers in Treated Post-Menopausal Women J. Am. Coll. Nutr., August 1, 2002; 21(4): 333 - 338. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Brousseau, J. J. O'Connor Jr, J. M. Ordovas, D. Collins, J. D. Otvos, T. Massov, J. R. McNamara, H. B. Rubins, S. J. Robins, and E. J. Schaefer Cholesteryl Ester Transfer Protein TaqI B2B2 Genotype Is Associated With Higher HDL Cholesterol Levels and Lower Risk of Coronary Heart Disease End Points in Men With HDL Deficiency: Veterans Affairs HDL Cholesterol Intervention Trial Arterioscler Thromb Vasc Biol, July 1, 2002; 22(7): 1148 - 1154. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Ordovas, L. A. Cupples, D. Corella, J. D. Otvos, D. Osgood, A. Martinez, C. Lahoz, O. Coltell, P. W. F. Wilson, and E. J. Schaefer Association of Cholesteryl Ester Transfer Protein-TaqIB Polymorphism With Variations in Lipoprotein Subclasses and Coronary Heart Disease Risk : The Framingham Study Arterioscler Thromb Vasc Biol, May 1, 2000; 20(5): 1323 - 1329. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Coresh and P. O. Kwiterovich Jr Small, Dense Low-Density Lipoprotein Particles and Coronary Heart Disease Risk: A Clear Association With Uncertain Implications JAMA, September 18, 1996; 276(11): 914 - 915. [Abstract] [PDF] |
||||
![]() |
B. F. Asztalos and P. S. Roheim Presence and Formation of `Free Apolipoprotein A-I–Like' Particles in Human Plasma Arterioscler Thromb Vasc Biol, September 1, 1995; 15(9): 1419 - 1423. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |